Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $12.6 Million - $14.3 Million
-262,538 Reduced 48.53%
278,407 $15.1 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $888,396 - $1.06 Million
-18,325 Reduced 3.28%
540,945 $27.8 Million
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $358,512 - $400,872
6,193 Added 1.12%
559,270 $32.5 Million
Q2 2023

Aug 01, 2023

SELL
$63.71 - $70.74 $127,802 - $141,904
-2,006 Reduced 0.36%
553,077 $35.4 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $889,319 - $1.01 Million
-13,534 Reduced 2.38%
555,083 $38.5 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $103,062 - $122,040
-1,505 Reduced 0.26%
568,617 $40.9 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $5,547 - $3.28 Million
42,676 Added 8.09%
570,122 $40.5 Million
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $2.55 Million - $2.81 Million
35,113 Added 7.13%
527,446 $40.6 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $8.71 Million - $10.4 Million
141,606 Added 40.37%
492,333 $36 Million
Q4 2021

Feb 03, 2022

SELL
$53.63 - $62.52 $942,171 - $1.1 Million
-17,568 Reduced 4.77%
350,727 $21.9 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $134,907 - $158,026
-2,280 Reduced 0.62%
368,295 $21.8 Million
Q2 2021

Aug 05, 2021

BUY
$61.91 - $67.42 $59,990 - $65,329
969 Added 0.26%
370,575 $24.8 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $9.97 Million - $11.2 Million
-168,037 Reduced 31.25%
369,606 $23.3 Million
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $146,948 - $166,519
-2,545 Reduced 0.47%
537,643 $33.4 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $1.54 Million - $1.7 Million
26,785 Added 5.22%
540,188 $32.6 Million
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $28.1 Million - $32.9 Million
513,403 New
513,403 $30.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Todd Asset Management LLC Portfolio

Follow Todd Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.